our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
DHRS2 expression
i
Other names: DHRS2, Dehydrogenase/Reductase 2, Dehydrogenase/Reductase SDR Family Member 2, Mitochondrial, Short Chain Dehydrogenase/Reductase Family 25C Member 1, Dehydrogenase/Reductase (SDR Family) Member 2, Dicarbonyl Reductase HEP27, Protein D, SDR25C1, Short Chain Dehydrogenase/Reductase Family 25C, Member 1, Short-Chain Alcohol Dehydrogenase Family Member, Dehydrogenase/Reductase Member 2, HEP27
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
The present study provides a mechanistic connection among metabolic enzymes, metabolites, and the malignant progression of CRC. Moreover, TCN could be developed as a potential pharmacological tool against CRC by the induction of DHRS2 and targeting SPHK1/S1P metabolic pathway.
With the emphasis on urologic malignancies (testicular germ cell tumors, urothelial-, prostate-, and renal cell carcinoma), this study concluded that elevated DHRS2 levels could be indicative of a successful HDACi treatment and, thereby offering a novel putative predictive biomarker.
The expression of STAMBPL1 mRNA is significantly up-regulated in LUAD, promoting the progression of LUAD by down-regulating the expression of DHRS2 and acting as a potential biomarker of LUAD.
over 2 years ago
Journal
|
DHRS2 (Dehydrogenase/Reductase 2) • STAMBPL1 (STAM Binding Protein Like 1)